08.10.2012 • News

Ineos, Accsys Form Tricoya JV

Ineos Technologies and Accsys Technologies have formed a 50:50 joint venture to further develop and commercialise Tricoya technology on a world wide basis. The new business will trade under the name of Tricoya Technologies.

As part of the agreement Accsys will grant the Joint Venture exclusive global rights to its proprietary acetylation technology for the production and licensing of Tricoya for use within medium density fibreboard (MDF), particle board and wood plastic composites.

 

 

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read